beta-alanine has been researched along with Pulmonary Disease, Chronic Obstructive in 5 studies
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As patients with chronic obstructive pulmonary disease (COPD) suffer from elevated exercise-induced muscle oxidative/carbonyl stress and acidosis, and from reduced muscle carnosine stores, it was investigated whether BA supplementation augments muscle carnosine and induces beneficial changes in exercise capacity, quadriceps function, and muscle oxidative/carbonyl stress in patients with COPD." | 3.11 | Efficacy of 12 weeks oral beta-alanine supplementation in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled trial. ( Barusso-Grüninger, MS; Blancquaert, L; Burtin, C; De Brandt, J; de Lima, FF; Derave, W; Hayot, M; Keytsman, C; Pomiès, P; Spruit, MA; Vandenabeele, F, 2022) |
| "A total of 222 patients with COPD (2×77 = 154 patients in the BASE-TRAIN trial and 2×34 = 68 patients in the BASE-ELECTRIC trial) will be recruited from two specialised PR centres in The Netherlands." | 2.94 | Beta-alanine supplementation in patients with COPD receiving non-linear periodised exercise training or neuromuscular electrical stimulation: protocol of two randomised, double-blind, placebo-controlled trials. ( Bij de Vaate, E; Burtin, C; de Brandt, J; Derave, W; Donkers, J; Everaert, I; Franssen, FME; Hayot, M; Klijn, P; Meys, R; Otker, JM; Pomiès, P; Schleich, FN; Sillen, MJH; Spruit, MA; Stoffels, AAF; van den Borst, B; van Hees, HWH; Wouters, EFM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Brandt, J | 2 |
| Derave, W | 2 |
| Vandenabeele, F | 1 |
| Pomiès, P | 2 |
| Blancquaert, L | 1 |
| Keytsman, C | 1 |
| Barusso-Grüninger, MS | 1 |
| de Lima, FF | 1 |
| Hayot, M | 2 |
| Spruit, MA | 2 |
| Burtin, C | 2 |
| Meys, R | 1 |
| Stoffels, AAF | 1 |
| van Hees, HWH | 1 |
| Franssen, FME | 1 |
| Sillen, MJH | 1 |
| Wouters, EFM | 1 |
| Klijn, P | 1 |
| Bij de Vaate, E | 1 |
| van den Borst, B | 1 |
| Otker, JM | 1 |
| Donkers, J | 1 |
| Schleich, FN | 1 |
| Everaert, I | 1 |
| Nicholls, DJ | 1 |
| Jordan, S | 1 |
| Cadogan, E | 1 |
| Lawson, M | 1 |
| Austin, RP | 1 |
| Paine, SW | 1 |
| Gardiner, P | 1 |
| Bonnert, R | 1 |
| Connolly, S | 1 |
| Young, A | 1 |
| Stöllberger, C | 1 |
| Rakusan, S | 1 |
| Wimpissinger, FT | 1 |
| Finsterer, J | 1 |
| de Gea-García, JH | 1 |
| Alvarez, M | 1 |
| Ruiz-Villa, G | 1 |
| Jiménez-Parra, JD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Oral β-Alanine Supplementation in Patients With COPD: Structural, Metabolic and Functional Adaptations[NCT02770417] | 60 participants (Actual) | Interventional | 2016-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for beta-alanine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy of 12 weeks oral beta-alanine supplementation in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled trial.
Topics: Aged; Antioxidants; beta-Alanine; Carnosine; Dietary Supplements; Exercise; Female; Humans; Male; Mi | 2022 |
Beta-alanine supplementation in patients with COPD receiving non-linear periodised exercise training or neuromuscular electrical stimulation: protocol of two randomised, double-blind, placebo-controlled trials.
Topics: beta-Alanine; Dietary Supplements; Double-Blind Method; Electric Stimulation; Exercise; Exercise The | 2020 |
3 other studies available for beta-alanine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
Topics: Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Benzothiaz | 2012 |
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillati | 2012 |
[Wünderlich syndrome in patient anticoagulated with dabigatran].
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia | 2013 |